The Wheel of FORTUNE just concluded an interview, part of SA partnership with Cheddar TV to produce a Seeking Alpha "Idea of the Month" slot. These interviews are always a challenge because i) they are very short in nature (only 4-5 minutes), and ii) since it's live TV we are dealing
Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health care agencies, such as the U.S. Food and Drug Administration (FDA), can make or break these companies.
Analysts often weigh in on these companies, and there are a number of factors that play a role in how analysts view....More>>>
Taxes needn’t be tough. When you boil it down, if you’re preparing your taxes, you compile everything you can deduct and try to save as much as you can.
But thieves know that they can get into your financial life by pressing the fear and hacking buttons. Although everybody wants some money back from the IRS, almost no one wants to hear from the agency.
S&W Seed Company (NASDAQ:SANW) files its latest 10-K with SEC for the fiscal year ended on June 30, 2017. S&W Seed Co is engaged in breeding, growing, processing and selling of alfalfa seed. It also offers seed cleaning and processing for other seed manufacturers. Its products include Alfalfa seed varieties and Stevia. S&W Seed Company has a market cap of $65.130 million; its shares....More>>>
Dont fight the trend is an oft-used expression on Wall Street. It may be truer now than ever. Casting a dubious eye on what has amounted to a spectacular rise for equity markets since Donald Trump became president-elect in November is proving a costly enterprise.
Whether the advance for equities can sustain itself over the next month and into 2017 is anyones guess, but for now investors who....More>>>
Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva....More>>>
On March 13th, 2018, CTS Labs announced that they have found no less than 13, yes, count them, 13 vulnerabilities in AMD's (AMD) Ryzen and EPYC architectures. To back up this claim they have had their findings reviewed by not less than ONE, yes, just one, company, Trail of Bits. To further bolst